HBM4EU is a joint effort of 30 countries, the European Environment Agency and the European Commission, co-funded under Horizon 2020.
The initiative is coordinating and advancing human biomonitoring in Europe. HBM4EU is generating evidence of the actual exposure of citizens to chemicals and the possible health effects in order to support policy making.
The HBM4EU initiative represents a novel collaboration between scientists and chemical risk assessors and risk managers, including several Commission services, EU agencies and representatives for the national level. The project has built bridges between the research and policy worlds in order to deliver benefits to society in terms of enhanced chemical safety.
HBM4EU is a five year project, that kicked off in 2017 and will run to the end of 2021.
In developing priorities for HBM4EU under the first annual work plan, the consortium conducted a prioritisation exercise in 2016 to identify those substances to be the focus of activities. A second round of prioritisation was conducted from 2017 to 2018. A third round of prioritisation is foreseen for 2020 to 2021, with the aim of feeding into a future initiative.
An introductory leaflet to HBM4EU is available in a range of languages. Please click on the language below to download the leaflet.
The HBM4EU project was launched in 2016 with the aim of improving the collective understanding of human exposure to hazardous chemicals and developing HBM as an exposure assessment method. The project had €74m in funding and jointly implemented by 120 partners from 28 participating countries – 24 EU member states plus Norway, Switzerland, Iceland and Israel and the European Environment Agency. One of its aims was to ensure the sustainability of HBM in the EU beyond 2021. The project ended in June 2022. The website will not be updated any longer, except the page on peer reviewed publications, but will be online until 2032.